This page contains a Flash digital edition of a book.
oncolog-hematolog
ro
hematologie
Chirurgie
Clinica de
Chir.Plastica
Chirurgie
oncologica
recuperare
2%
2%
2%
2%
Balneofizioterapie
2%
Ginecologie
2%
Urologie
3% ORL
2%
Neurologie
3%
Chirurgie toracica
Medicala
3%
31%
Pneumoftiziologie
5%
Dializa
5%
Cardiologie
5%
Gastroenterologie
10% Figura 30.
Neurochirurgie
Nefrologie
Profilul clinicilor care
10%
10% au formulat suspiciunea
de MM
Sindrom anemic
Discopatie lombara. Sciatalgii
2%2%
1%
Tumora toracica
2%
Gamapatie monoclonala
8%
18%
GNC.IRC
2%
Radiculonevrita
2%
Parapareza
Reumatism degenerativ
2% 13%
Tumora fronto-parietala
Discartroza cervico-dorso-lombara
2%
Gonalgie stanga
2% HDS
Hipoplazie medulara
2%
Neoplasm digestiv
12%
3%
Sindrom hepatosplenomegalic
3% Sindrom paraneoplazic
2%
Sindrom Raynaud
4%
5%
5%
Sindrom subfebril prelungit
Figura 31.
SMPC-PV
Structura diagnosticelor
Neoplasm pulmonar
de “împrumut”
Bibliografie
1. Bergsagel P.L. Prognostic factors in multiple myeloma: it’s in the genes. Clin Cancer stem cell transplantation: t(4;14) is the most relevand adverse prognostic factor,
Res 2003; 9:533-4. whereas RB deletion as a unique abnormality is not associated with adverse prog-
2. Bataille R., Jego G., Robillard N. et al. The phenotype of normal, reactive and ma-
nosis. Leukemia 2007; 21:143-50.
lignant plasma cells. Identification of „many and multiple myeloma” and of new
7. San Miguel J.F., Garcia-Sanz R. Prognostic features of multiple myeloma. Best Pract
targets for myeloma therapy. Haematologica 2006; 91: 1234-64.
Res Clin Haematol 2005; 18:569-83.
3. Robillard N., Pellat-Deceunynck C., Bataille R. Phenotypic characteriyation of the
8. Blade J., Kyle R.A., Greipp P.R. Presenting features and prognosis in 72 patients with
human myeloma cell growth fraction. Blood 2005; 105: 4845-8.
multiple myeloma who were younger than 40 years. Br J Haematol 1996; 93:345-
4. Kumar S., Rajkumar S.V., Kimlinger T. et al. CD45 expression by bone marrow
plasma cells in multiple myeloma: clinical and biological correlations. Leukemia
51.
2005; 19:1466-70.
9. Moulopoulos L.A., Gika D., Anagnostopoulos A. et al. Prognostic significance of
5. Avet-Loiseau H., Attal M., Moureau P. et al. Genetic abnormalities in myeloma: teh
magnetic resonance imaging of bone marrow in previously untreated patients
experience of the Intergroupe Francophone du Myélome. Blood 2007; 109:3489-
with multiple myeloma. Ann Oncol 2005; 16:1824-8.
95.
10. Knobel R.A., Therneau T.M., Rajkumar S.V. et al. A long-term study of prognosis
6. Gutierrey N.C., Castellanos M.V., Moureau P. et al. Prognostic and biological im- plasmacytoma of the bone: a multicenter rare cancer network study. BMC Cancer
plications of genetic abnormalities in multiple myeloma undergoing autologous 2006; 6:118.
pag. 64
Nr. 7 (2)/2009
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68
Produced with Yudu - www.yudu.com